Literature DB >> 8969212

Purification and kinetic characterization of the mitogen-activated protein kinase phosphatase rVH6.

A M Wiland1, J M Denu, R J Mourey, J E Dixon.   

Abstract

The dual specificity protein-tyrosine phosphatase rVH6 belongs to a subfamily of enzymes that have in vivo and in vitro catalytic activity against mitogen-activated protein kinases. A method was developed for the expression and efficient purification of recombinant rVH6 in quantities sufficient for physical and kinetic characterization of the enzyme. Matrix-assisted laser desorption mass spectrometry verified the mass of purified rVH6 to be 43,500 +/- 150, and NH2-terminal sequence analysis confirmed the predicted amino acid sequence. Kinetic characterization of full-length rVH6 identified the critical ionizations involved in the kcat/Km parameter (apparent pKa values 5.1 and 6.6) and revealed a pH-independent kcat value of 0.014 s-1. In an attempt to define the essential catalytic core of this enzyme, amino acids 134-381 of rVH6 were expressed, purified, and characterized enzymatically. Kinetic analysis revealed that the truncated enzyme exhibited a turnover value similar to that of the full-length enzyme (kcat = 0.017 s-1), with p-nitrophenyl phosphate as substrate. Secondary structure prediction and molecular modeling of rVH6 based on the x-ray structure of the dual specificity protein tyrosine phosphatase, VHR, further supported the assignment of residues 134-381 to the core catalytic domain of rVH6. These results demonstrate that the NH2 terminus of rVH6 (residues 1-133) is not required for full enzyme activity and comprises a separate domain that may play a distinct physiological function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969212     DOI: 10.1074/jbc.271.52.33486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

2.  Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha.

Authors:  Yuan-Yuan Zhang; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

3.  MEK/ERK pathway mediates insulin-promoted degradation of MKP-3 protein in liver cells.

Authors:  Bin Feng; Ping Jiao; Zaiqing Yang; Haiyan Xu
Journal:  Mol Cell Endocrinol       Date:  2012-04-12       Impact factor: 4.102

Review 4.  Protein tyrosine phosphatases: structure, function, and implication in human disease.

Authors:  Lutz Tautz; David A Critton; Stefan Grotegut
Journal:  Methods Mol Biol       Date:  2013

5.  Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking.

Authors:  Ole Valente Mortensen; Mads Breum Larsen; Balakrishna M Prasad; Susan G Amara
Journal:  Mol Biol Cell       Date:  2008-04-23       Impact factor: 4.138

6.  Dual specificity phosphatases 18 and 21 target to opposing sides of the mitochondrial inner membrane.

Authors:  Matthew J Rardin; Sandra E Wiley; Anne N Murphy; David J Pagliarini; Jack E Dixon
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.